MedPath

Comparing the passage of breathing tube into the windpipe using, either an IGel or BlockBuster LMA which are two different types of breathing devices

Not Applicable
Completed
Conditions
Health Condition 1: O- Medical and Surgical
Registration Number
CTRI/2020/05/024999
Lead Sponsor
Sanjay Gandhi Post Graduate Institute of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
160
Inclusion Criteria

ASA I-II patients,

Body Mass Index <30 kg/m2

All elective surgical procedures requiring tracheal intubation

Adequate mouth opening : >2 fingers

Mallampati Grade 1 - 4

Exclusion Criteria

ASA III-V

Body Mass Index >30 kg/m2

Emergency Procedures

Contraindications to supraglottic airway devices

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To compare success rate of fibreoptic guided tracheal intubation through I-GelTM and BlockBusterTM supraglottic airway devicesTimepoint: Immediately after confirmed endo tracheal intubation(confirmed by chest rise, capnogram and auscultation)
Secondary Outcome Measures
NameTimeMethod
1 Insertion time of supraglottic devices <br/ ><br>2 Oropharyngeal leak pressure in neutral position <br/ ><br>3 Fibreoptic view scoring system <br/ ><br>4 Intubation time through the device <br/ ><br>5 Incidence of post op complications <br/ ><br>Timepoint: 1 Insertion time of supraglottic devices:After successful placement of IGel or BlockBuster LMA <br/ ><br>2.Oropharyngeal leak pressure in neutral position:After successful placement of IGel or BlockBuster LMA <br/ ><br>3Fibreoptic view scoring system: After successful placement of IGel or BlockBuster LMA <br/ ><br>4 Intubation time through the device: After successful endotracheal intubation fibreoptically through the IGel or BlockBuster LMA <br/ ><br>5.Incidence of post op complications: After 24 hours of extubation <br/ ><br>
© Copyright 2025. All Rights Reserved by MedPath